BioCryst Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCRX Nasdaq 2830 www.biocryst.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCryst Pharmaceuticals, Inc.

BioCryst to Report Second Quarter 2026 Financial Results on August 5 - Jul 22nd, 2026 5:00 am
BioCryst Appoints David W. Jenkins as Chief Scientific Officer - Jul 15th, 2026 5:00 am
Wall Street Analysts Think BioCryst (BCRX) Could Surge 117.96%: Read This Before Placing a Bet - Jul 14th, 2026 7:55 am
BioCryst (BCRX) Stock Looks Below Fair Value As Caution Lingers - Jul 9th, 2026 1:13 am
Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs? - Jul 8th, 2026 9:39 pm
BioCryst Pharmaceuticals (BCRX) Ends Internal Discovery And Closes Birmingham Facility - Jul 8th, 2026 8:11 pm
BioCryst (BCRX) Surges 8.1%: Is This an Indication of Further Gains? - Jul 8th, 2026 8:14 am
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal? - Jul 7th, 2026 11:11 pm
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today? - Jul 7th, 2026 9:34 pm
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 2nd, 2026 5:00 am
BioCryst to Discontinue Internal Discovery Programs, Close Birmingham Facility by Year-End - Jun 29th, 2026 6:06 am
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility - Jun 29th, 2026 5:00 am
BCRX Stock Set For Best Week In Over 3 Months – Retail Shifts Focus To This Crucial Breakout Level - Jun 25th, 2026 10:50 am
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting - Jun 12th, 2026 5:00 am
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now? - Jun 11th, 2026 2:31 pm
WCG Appoints Anthony Doyle as Chief Financial Officer to Support Continued Growth and Operational Scale - Jun 11th, 2026 7:00 am
BioCryst Pharmaceuticals Backs ORLADEYO Outlook as Navenibart Trial Advances - Jun 6th, 2026 1:12 am
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting - May 27th, 2026 5:00 am
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026 - May 13th, 2026 5:00 am
BioCryst (BCRX) Is Down 6.7% After Q1 Loss And Navenibart Deal News Has The Bull Case Changed? - May 12th, 2026 10:18 am